Haemochromatosis and the liver

Journal of Hepatology, Supplement

Volumn 30, Issue 1, 1999, Pages 6-11

  Niederau, Claus ^a  

^a St Josef Hospital Oberhausen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSIDERIN; IRON; TRANSFERRIN;

CONFERENCE PAPER; DISEASE ASSOCIATION; HEMOCHROMATOSIS; HEMOLYTIC ANEMIA; IRON KINETICS; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER TUMOR; MASS SCREENING; PATHOGENESIS; PHLEBOTOMY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

GENETIC SCREENING; HEMOCHROMATOSIS; HUMANS; LIVER DISEASES; MASS SCREENING; TERMINOLOGY;

EID: 0032939298     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Feder JN, Gnirke A, Thoraas W, Tsuchihashi Z, Ruddy DA, Ba- . sava A, et al. A novel MCH class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 1996; 13: 399
2. Merrywether-Clarke AT, Pointon JJ, Sherman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-8.
3. Parkkila S, Waheed A, Britton RS, Bacon BB, Zhou XY, Tomatsu S, et al. Association of the transferrin receptor in human placenta with the HFE protein defective in hereditary hemochromatosis. Proc Natl Acad Sei USA 1997; 13198-202.
4. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sei USA 1998; 95; 1472-7.
5. Lebron JA, Bennett MJ, Vauhn DE, Chirino AJ, Snow PM, Mintier GA, et al. Crystal structures of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998; 93: 111-23.
6. Waheed A, Parkkila S, Zhou XY, Tomatsou S, Tsuchihashi Z, Feder JN, et al. Hereditary hemochromatosis: effects of Cys282Tyr and H63D mutations on associations with -microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sei USA 1997; 94: 123849.
7. Parkkila S, Waheed A, Britton RS. Immunohistochemistry of the HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals a unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sei USA 1997; 94: 2534-9.
8. Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996; 110: 1107-19.
9. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. New Engl J Med 1988; 318: 1355-62.
10. Niederau C, Niederau CM, Littauer A, Abdd-Jalil N, Maurer M, Häussinger D, Strohmeyer G. Screening for iron overload and iron deficiency. Ann Int Med 1998; 128: 337-45.
11. Loreal O, Deugnier Y, Moirand R et al. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron related factors in 127 homozygous patients. J Hepatol 1992; 16: 122-7.
12. Grootveld M, Bell JD, Halliwell B. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. J Biol Chem 1989; 264: 4417-22.
13. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and noncirrhotic patients with primary haemochromatosis. New Engl J Med 1985; 313: 1256-62.
14. Deugnier Y, Batttistelli D, Jouanolle H, Guyader D, Gueguen M, Loeal O, et al. Hepatitis B virus infection markers in genetic haemochromatosis. J Hepatol 1992; 13: 286-90.
15. Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti RG, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992; 16: 3603.
16. Niederau C, Berger M, Stremmel W. Hyperinsulinaemia in noncirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 1984; 26: 441-4.
17. Kley HK, Niederau C, Stremmel W. Conversion of androgens to estrogens in idiopathic hemochromatosis: comparison with alcoholic cirrhosis. J Clin Endocrinol Metab 1985; 61: 1-6.
18. Finch SC, Finch CA, Idiopathic hemochromatosis, an iron storage disease. Medicine 1966; 34: 381
19. von Herbay A, Niederau C, Pelichowska M, Reinecke P, Perings C, Vester E, et al. Kardiomyopathie als Todesursache bei genetischer Hämochromatose. Z Gastroenterol 1996; 34: 178-82.
20. Fargion S, Mandelli C, Piperno A. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992; 15: 655-9.
21. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991; 101: 368-72.
22. Muting D, Kalk JF, Fischer R, Wiewel D. Spontaneous regression of oesophageal varices after long-term conservative treatment. Retrospective study in 20 patients with alcoholic liver disease, posthepatitic cirrhosis and haemochromatosis with cirrhosis. J Hepatol 1990; 10: 158-62.